THEMIS MEDICARE
Back to Balance Sheet
|
THEMIS MEDICARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹29 Cr | ₹36 Cr | ₹35 Cr | ₹31 Cr | ₹24 Cr |
What is the latest Total Non-Current Liabilities ratio of THEMIS MEDICARE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹29 Cr |
| Mar2024 | ₹36 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹31 Cr |
| Mar2021 | ₹24 Cr |
How is Total Non-Current Liabilities of THEMIS MEDICARE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹29 Cr | -18.07 | |
| Mar2024 | ₹36 Cr | 1.09 | |
| Mar2023 | ₹35 Cr | 14.99 | |
| Mar2022 | ₹31 Cr | 26.50 | |
| Mar2021 | ₹24 Cr | - | |
Compare Total Non-Current Liabilities of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹824.2 Cr | -1.7% | 10% | -52.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | -1.7% |
10% |
-52.8% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses